News
Important Only
NYSE Enters Agreement With Msci To Become The U.S. Options Listing Venue For Benchmark Indexes
Jan 7 (Reuters) - Intercontinental Exchange Inc ICE.N:THE NEW YORK STOCK EXCHANGE ENTERS AGREEMENT WITH MSCI TO BECOME THE U.S. OPTIONS LISTING VENUE FOR BENCHMARK INDEXES IN EARLY 2026NEW YORK STOCK EXCHANGE-ANNOUNCES AGREEMENT WITH MSCINEW YORK STOCK EXCHANGE: TO LIST MSCI INDEX OPTIONS IN 2026NEW...Reuters
Wed, Jan 7
HSG's continuation fund to value ByteDance at up to $370 billion, sources say
HSG owns just over 11% of the TikTok parent, source saysByteDance valued at as much as $480 billion in November secondary trade, sources sayByteDance profit could reach $48 billion in 2025, sources sayBy Kane Wu HONG KONG, Jan 7 (Reuters) - Venture capital firm HSG, formerly Sequoia Capital China...Reuters
Wed, Jan 7
Kelonia Therapeutics Announces FDA Clearance Of Investigational New Drug Application For Kln-1010
Jan 7 (Reuters) - KELONIA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR KLN-1010, AN IN VIVO BCMA CAR-T THERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMAFurther company coverage: [ ]Reuters
Wed, Jan 7
Exelixis And Natera To Collaborate On Stellar-316, A Phase 3 Pivotal Trial Of Zanzalintinib
Jan 7 (Reuters) - Exelixis Inc EXEL.O:EXELIXIS AND NATERA TO COLLABORATE ON STELLAR-316, A PHASE 3 PIVOTAL TRIAL OF ZANZALINTINIB FOR PATIENTS WITH COLORECTAL CANCEREXELIXIS INC - EXPECTS TO INITIATE STELLAR-316 IN MID-2026Reuters
Wed, Jan 7
Protara Therapeutics Announces Dosing Of First Patient In Phase 3 Registrational Thrive-3 Trial
Jan 7 (Reuters) - Protara Therapeutics Inc TARA.O:PROTARA THERAPEUTICS ANNOUNCES DOSING OF FIRST PATIENT IN PHASE 3 REGISTRATIONAL THRIVE-3 TRIAL OF IV CHOLINE CHLORIDE IN PATIENTS ON LONG-TERM PARENTERAL SUPPORTReuters
Wed, Jan 7
Switzerland says any change to Greenland's status requires consent of Denmark and Greenland
ZURICH, Jan 7 (Reuters) - Any change to Greenland's status requires the consent of Denmark and Greenland, the Swiss foreign ministry said on Wednesday following a renewed threat by U.S. President Donald Trump to take over the Danish territory.Asked for its position on recent remarks by U.S. gove...Reuters
Wed, Jan 7
Alaska Airlines orders 110 Boeing planes in expansion plan
WASHINGTON, Jan 7 (Reuters) - Alaska Airlines is ordering 110 new Boeing planes, the largest single order in the airline's history, it said on Wednesday.Seeking to expnad operations, the airline said it is ordering 105 737 MAX 10 aircraft and five new 787-10 jets. The additional planes will allo...Reuters
Wed, Jan 7
CANADA FX DEBT - Canadian dollar strengthens, benchmark yield slips
The Canadian dollar strengthened against the greenback on Wednesday, and the yield on benchmark government debt slipped. The loonie CAD= was trading 0.1% higher at C$1.3795 to the greenback, or 72.49 U.S. cents, after trading in a range of 1.3795 to 1.3826.Canadian government 10-year bond yields CA1...Reuters
Wed, Jan 7
Spotify makes it easier for creators to earn, reveals $10 billion podcast spend
Spotify lowers eligibility for its partner programCompany announces Spotify Sycamore StudiosCreators can monetize via third-party platforms with new APISpotify's new sponsorship tools to launch in AprilBy Jaspreet SinghJan 7 (Reuters) - Spotify is expanding its monetization program for creators ...Reuters
Wed, Jan 7
Verrica Pharmaceuticals Announces First Patient Dosed In Phase 3 Program
Jan 7 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O:VERRICA PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN PHASE 3 PROGRAM EVALUATING YCANTH® (VP-102) FOR THE TREATMENT OF COMMON WARTSVERRICA PHARMACEUTICALS INC - TORII TO FUND FIRST $40 MILLION OF PHASE 3 TRIAL COSTSReuters
Wed, Jan 7
